Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 OncoSignature-negative) are being presented • A 50% confirmed overall ...

RecommendThanks for recommending this page! The page you recommended will be added to the "what others are reading" feed on "My ACR". Last month, the ACR announced Alan H. Matsumoto, MD, FACR, as ...

The RFS facilitates 2 journal clubs, on the topics of Artificial Intelligence and Economics. These journal clubs let trainees interact directly with ACR leaders and gain their unique perspectives on ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of ...